CORONARY EFFECTS OF NICORANDIL IN COMPARISON WITH NITROGLYCERIN IN CHRONIC CONSCIOUS DOGS

被引:41
作者
HASHIMOTO, K [1 ]
KINOSHITA, M [1 ]
OHBAYASHI, Y [1 ]
机构
[1] SHIGA UNIV MED SCI,DEPT INTERNAL MED 1,OTSU,SHIGA 52021,JAPAN
关键词
NICORANDIL; NITROGLYCERIN; CORONARY ARTERY DIAMETER; CORONARY BLOOD FLOW; CONSCIOUS DOGS;
D O I
10.1007/BF03029808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of nicorandil (0.2 mg/kg, IV) and nitroglycerin (15-mu-g/kg, IV) on large and small coronary arteries were compared in conscious dogs instrumented with ultrasonic crystals and electromagnetic flow meters in the circumflex coronary artery. Nicorandil dilated the large coronary arteries to the same extent, but with a longer duration of action than nitroglycerin. The small coronary arteries dilated for a very short period of time with nitroglycerin, but dilated markedly with nicorandil. The dilatory action of nicorandil on large coronary arteries persisted after the action on the small coronary artery fell to the control value, indicating that the dilatory action on the large coronary arteries is due to the direct relaxing effect on smooth muscle and is not the result of the flow-dependent effect. The measurement of the plasma concentration of nicorandil after incremental infusions of the agent showed that the dilation of the small coronary artery took place at only a very high level (above 200 ng/ml). On the other hand, the large coronary arteries responded to nicorandil at a much lower concentration (about 100 ng/ml, the clinically effective plasma concentration of nicorandil) than the small coronary resistance arteries. In conclusion, whereas nicorandil possesses a dilatory action on both large and small coronary arteries, in a clinical setting, with a daily dosage of 15-30 mg, part of the beneficial effects of nicorandil may be the result of a dilation of the large coronary arteries and may be due to the fact that a coronary steal phenomenon does not occur after nicorandil administration.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 38 条
  • [1] Uchida Y., Yoshimoto N., Murao S., Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation, Jpn Heart J, 19, pp. 112-124, (1977)
  • [2] Uchida Y., Yoshimoto N., Murao S., Effects of antianginal agents on cyclical reductions of coronary blood flow, Jpn Heart J, 19, pp. 904-912, (1978)
  • [3] Taira N., Satoh K., Yanagisawa T., Et al., Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidethyl nitrate (SG 75), Clin Exp Pharmacol Physiol, 6, pp. 301-316, (1979)
  • [4] Taira N., Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrate: An overview, J Cardiovasc Pharmacol, 10, pp. s1-s9, (1987)
  • [5] Holzman S., Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75), Journal of Cardiovascular Pharmacology, 5, pp. 364-370, (1983)
  • [6] Endoh M., Taira N., Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery, Naunyn Schmiedebergs Arch Pharmacol, 322, pp. 319-321, (1983)
  • [7] Endoh M., Iijima T., Effects of nicorandil and its interaction with isoproterenol on force of contraction cyclic nucleotide levels of canine atrial muscle: Comparison with carbachol, J Cardiovasc Pharmacol, 5, pp. 878-882, (1983)
  • [8] Yanagisawa T., Taira N., Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidethyl nitrate (SG-75), Jpn J Pharmacol, 29, pp. 687-694, (1979)
  • [9] Yanagisawa T., Taira N., Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left arterial muscle fibers of the dog. Increase in potassium conductance, Naunyn Schmiedebergs Arch Pharmacol, 312, pp. 69-76, (1980)
  • [10] Yanagisawa T., Taira N., Effects of 2-nicotinamidethyl nitrate (SG-75) on membrane potentials of canine Purkinje fibers, Jpn J Pharmacol, 31, pp. 409-417, (1981)